Navin Fluorine International (532504) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
29 Apr, 2026Executive summary
Achieved six consecutive quarters of revenue and profitability growth, with FY26 consolidated sales reaching ₹3,379.19 crore, up 41% year-over-year, and operating EBITDA of ₹1,081.7 crore, up 103% year-over-year.
Declared a final dividend of ₹8.60 per share (430% of face value), following an interim dividend of ₹6.50 per share, reflecting strong performance and confidence in future growth.
All business segments—HPP, Specialty Chemicals, and CDMO—delivered strong revenue growth, with CDMO leading at 61% YoY in Q4.
Annual audited standalone and consolidated financial results for FY26 were approved with unmodified audit opinions.
Board approved re-appointments of key directors and set record date for dividend eligibility as June 12, 2026.
Financial highlights
Q4 FY26 consolidated revenue: ₹937.7 crore, up 34% year-on-year; Q4 operating EBITDA: ₹321.2 crore, up 80% year-on-year, with margin expansion to 34.2%.
FY26 consolidated revenue: ₹3,379.19 crore, up from ₹2,393.11 crore in FY25; FY26 operating EBITDA: ₹1,081.7 crore, margin at 32.6%, up 992 bps.
FY26 profit after tax: ₹663.55 crore, up from ₹288.58 crore; Q4 profit after tax: ₹212.6 crore, up 124% year-on-year.
Net working capital days improved to 74 from 90; guidance for 75-80 days going forward.
Exceptional item gain of ₹13.72 crore in Q4 FY26 due to reversal of excess Labour Code provision.
Outlook and guidance
CapEx projects underway in HFC, MPP, Advanced Materials, and KMOS, with total planned investments exceeding ₹430 crore, funded mainly by internal accruals.
Commissioning and ramp-up of additional HFC capacities (32 MPP) and KMOS project expected in the coming year.
Margin guidance maintained at ~30% for FY27, with expected fluctuations of 1-2%.
Double-digit revenue growth anticipated for specialty chemicals and HPP segments in FY27.
Strong order visibility and positive outlook across all business segments, with new product launches and capacity expansions scheduled for FY27.
Latest events from Navin Fluorine International
- Strong revenue and profit growth, margin expansion, and positive outlook driven by capex.532504
Q3 25/269 Feb 2026 - Revenue up 7% YoY, HPP up 66%, specialty and CDMO down, capex and margins set to improve.532504
Q1 24/252 Feb 2026 - Q2 FY25 revenue up 10% YoY, HPP/CDMO strong, interim dividend and capex progress announced.532504
Q2 24/2519 Jan 2026 - Q3 FY25 delivered strong revenue, margin growth, and a ₹5/share interim dividend.532504
Q3 24/259 Jan 2026 - Record revenue, profit, ₹7/share dividend, and ₹750 crore fund raise approved for growth.532504
Q4 24/256 Jan 2026 - Q1 FY26 saw strong revenue and profit growth, margin expansion, and a ₹750 crore QIP for growth.532504
Q1 25/266 Jan 2026 - Q2 FY26 revenue up 46%, EBITDA margin at 32.5%, with major capex and interim dividend declared.532504
Q2 25/261 Nov 2025